UBS AM’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Buy
206,884
+1,451
+0.7% +$34.7K ﹤0.01% 1595
2025
Q4
$5.49M Sell
205,433
-5,682
-3% -$136K ﹤0.01% 1416
2025
Q3
$4.51M Sell
211,115
-131,767
-38% -$3.12M ﹤0.01% 1418
2025
Q2
$7.4M Buy
342,882
+91,826
+37% +$1.71M ﹤0.01% 1510
2025
Q1
$4.17M Buy
251,056
+31,931
+15% +$580K ﹤0.01% 1661
2024
Q4
$4.02M Buy
219,125
+29,386
+15% +$474K ﹤0.01% 1717
2024
Q3
$2.92M Sell
189,739
-27,856
-13% -$465K ﹤0.01% 1836
2024
Q2
$3.54M Buy
217,595
+98,252
+82% +$1.59M ﹤0.01% 1688
2024
Q1
$2.21M Sell
119,343
-3,005
-2% -$74.4K ﹤0.01% 1649
2023
Q4
$3.83M Buy
122,348
+3,605
+3% +$86.1K ﹤0.01% 1379
2023
Q3
$2.47M Sell
118,743
-7,872
-6% -$214K ﹤0.01% 1518
2023
Q2
$2.38M Hold
126,615
﹤0.01% 1568
2023
Q1
$2.38M Buy
+126,615
New +$2.41M ﹤0.01% 1568
2022
Q4
Sell
-123,201
Closed -$2.02M 2525
2022
Q3
$2.02M Sell
123,201
-491,336
-80% -$7.96M ﹤0.01% 1591
2022
Q2
$8.66M Buy
614,537
+42,192
+7% +$787K ﹤0.01% 1009
2022
Q1
$13.9M Buy
572,345
+30,352
+6% +$734K 0.01% 947
2021
Q4
$12.7M Buy
541,993
+78,185
+17% +$1.57M ﹤0.01% 1041
2021
Q3
$7.7M Sell
463,808
-21,129
-4% -$407K ﹤0.01% 1191
2021
Q2
$11.8M Buy
484,937
+81,312
+20% +$1.84M 0.01% 1059
2021
Q1
$10.4M Sell
403,625
-171,220
-30% -$7.54M ﹤0.01% 1075
2020
Q4
$30.7M Sell
574,845
-14,881
-3% -$739K 0.01% 735
2020
Q3
$24.3M Sell
589,726
-329,928
-36% -$14.2M 0.01% 714
2020
Q2
$44.6M Buy
919,654
+144,052
+19% +$6.92M 0.03% 526
2020
Q1
$32.8M Sell
775,602
-85,195
-10% -$3.51M 0.02% 570
2019
Q4
$36.8M Buy
860,797
+749,288
+672% +$32.6M 0.02% 613
2019
Q3
$4.01M Buy
111,509
+6,942
+7% +$211K ﹤0.01% 1296
2019
Q2
$2.8M Buy
104,567
+10,273
+11% +$262K ﹤0.01% 1429
2019
Q1
$2.53M Buy
94,294
+13,099
+16% +$306K ﹤0.01% 1410
2018
Q4
$1.31M Buy
81,195
+12,647
+18% +$246K ﹤0.01% 1622
2018
Q3
$1.42M Buy
68,548
+19
+0% +$299 ﹤0.01% 1648
2018
Q2
$1.05M Sell
68,529
-543,117
-89% -$9.68M ﹤0.01% 1803
2018
Q1
$13.7M Sell
611,646
-277,730
-31% -$7.69M 0.01% 846
2017
Q4
$26.8M Buy
889,376
+103,583
+13% +$3.31M 0.02% 666
2017
Q3
$29.6M Buy
785,793
+14,226
+2% +$463K 0.03% 616
2017
Q2
$21.5M Buy
771,567
+61,200
+9% +$1.82M 0.02% 718
2017
Q1
$24.4M Buy
710,367
+19,024
+3% +$672K 0.02% 649
2016
Q4
$19.9M Sell
691,343
-25,593
-4% -$677K 0.02% 677
2016
Q3
$22.8M Buy
716,936
+59,780
+9% +$2.03M 0.02% 635
2016
Q2
$21.3M Sell
657,156
-148,328
-18% -$4.96M 0.02% 652
2016
Q1
$22.5M Buy
805,484
+39,224
+5% +$855K 0.03% 616
2015
Q4
$27.3M Buy
766,260
+2,885
+0.4% +$102K 0.03% 543
2015
Q3
$25.2M Sell
763,375
-81,802
-10% -$3.4M 0.03% 593
2015
Q2
$35.4M Buy
845,177
+164,046
+24% +$6.35M 0.03% 528
2015
Q1
$22.2M Buy
681,131
+1,500
+0.2% +$51.6K 0.02% 676
2014
Q4
$21.6M Buy
679,631
+647,100
+1,989% +$18.4M 0.02% 679
2014
Q3
$805K Buy
32,531
+100
+0.3% +$2.34K ﹤0.01% 1637
2014
Q2
$733K Hold
32,431
﹤0.01% 1699
2014
Q1
$789K Buy
32,431
+12,231
+61% +$309K ﹤0.01% 1649
2013
Q4
$505K Sell
20,200
-9,800
-33% -$231K ﹤0.01% 1802
2013
Q3
$824K Buy
30,000
+11,900
+66% +$249K ﹤0.01% 1575
2013
Q2
$329K Buy
+18,100
New +$249K ﹤0.01% 1939

Other funds holding ACAD